Sustained Exposure of Substance P Causes Tendinopathy
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Recently, neuromediators such as substance P (SP) have been found to be important factors in tendon homeostasis. Some studies have found SP to be the cause of inflammation and tendinopathy, whereas others have determined it to be a critical component of tendon healing. As demonstrated by these conflicting findings, the effects of SP on tendinopathy remain unclear. In this study, we hypothesized that the duration of SP exposure determines its effect on the tendons, with repetitive long-term exposure leading to the development of tendinopathy. First, we verified the changes in gene and protein expression using in vitro tenocytes with 10-day exposure to SP. SP and SP + Run groups were injected with SP in their Achilles tendon every other day for 14 days. Achilles tendons were then harvested for biomechanical testing and histological processing. Notably, tendinopathic changes with decreased tensile strength, as observed in the Positive Control, were observed in the Achilles in the SP group compared to the Negative Control. Subsequent histological analysis, including Alcian blue staining, also revealed alterations in the Achilles tendon, which were generally consistent with the findings of tendinopathy in SP and SP + Run groups. Immunohistochemical analysis revealed increased expression of SP in the SP group, similar to the Positive Control. In general, the SP + Run group showed worse tendinopathic changes. These results suggest that sustained exposure to SP may be involved in the development of tendinopathy. Future research on inhibiting SP is warranted to target SP in the treatment of tendinopathy and may be beneficial to patients with tendinopathy.
Pan H, Shi X, Jiang Y, Wu J, Shen L Sci Rep. 2024; 14(1):31201.
PMID: 39732926 PMC: 11682360. DOI: 10.1038/s41598-024-82575-5.
Is Chronic Tendon Pain Caused by Neuropathy? Exciting Breakthroughs may Direct Potential Treatment.
Palee S, Yener U, Abd-Elsayed A, Wahezi S Curr Pain Headache Rep. 2024; 28(12):1235-1239.
PMID: 39028489 DOI: 10.1007/s11916-024-01299-3.
Shin D, Lee Y, An H, Hwang T, Cho J, Oh J Front Endocrinol (Lausanne). 2023; 14:1238654.
PMID: 37795375 PMC: 10546412. DOI: 10.3389/fendo.2023.1238654.
Animal model for tendinopathy.
Luo J, Wang Z, Tang C, Yin Z, Huang J, Ruan D J Orthop Translat. 2023; 42:43-56.
PMID: 37637777 PMC: 10450357. DOI: 10.1016/j.jot.2023.06.005.
Substance P, A Promising Therapeutic Target in Musculoskeletal Disorders.
Ko K, Lee H, Han S, Ahn W, Kim D, Kim I Int J Mol Sci. 2022; 23(5).
PMID: 35269726 PMC: 8910130. DOI: 10.3390/ijms23052583.